BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18971845)

  • 21. [Malignant mesothelioma].
    Scherpereel A
    Rev Prat; 2009 Jun; 59(6):751-5. PubMed ID: 19642427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment option.
    Razak AR; Chatten KJ; Hughes AN
    Lung Cancer; 2008 May; 60(2):294-7. PubMed ID: 17919769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting.
    Ampollini L; Soltermann A; Felley-Bosco E; Lardinois D; Arni S; Speck RF; Weder W; Opitz I
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):457-62. PubMed ID: 19162494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malignant pleural mesothelioma. II. Modern therapeutic concepts].
    Dagović A; Jeremić B
    Srp Arh Celok Lek; 1998; 126(11-12):472-7. PubMed ID: 9921022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the treatment of malignant pleural mesothelioma.
    Ramalingam SS; Belani CP
    J Thorac Oncol; 2008 Sep; 3(9):1056-64. PubMed ID: 18758312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimising survival in malignant mesothelioma.
    Baas P
    Lung Cancer; 2007 Aug; 57 Suppl 2():S24-9. PubMed ID: 17686442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future developments in the management of malignant pleural mesothelioma.
    Zucali PA; De Vincenzo F; Simonelli M; Santoro A
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):453-67. PubMed ID: 19374599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [First-line treatment with pemetrexed in association with cisplatin in patients with non-operable malignant pleural mesothelioma].
    Burgin M; Gairard-Dory A-; Mennecier B; Molard A; Beretz L; Quoix A-
    Rev Pneumol Clin; 2009 Apr; 65(2):75-83. PubMed ID: 19375046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant pleural mesothelioma: a new standard of care.
    Stahel RA
    Lung Cancer; 2006 Dec; 54 Suppl 2():S9-S14. PubMed ID: 17059852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
    Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
    Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
    Li L; Razak AR; Hughes A
    Lung Cancer; 2009 May; 64(2):207-10. PubMed ID: 18926592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical types of thoracic cancer. Pleural mesothelioma].
    Astoul P
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S177-16S187. PubMed ID: 17268356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of apoptosis by intrapleural perfusion hyperthermo-chemotherapy for malignant pleural mesothelioma.
    Matsuzaki Y; Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2008 Jun; 14(3):161-5. PubMed ID: 18577894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodality strategies in malignant pleural mesothelioma.
    Weder W; Opitz I; Stahel R
    Semin Thorac Cardiovasc Surg; 2009; 21(2):172-6. PubMed ID: 19822290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant mesothelioma 2008.
    Zervos MD; Bizekis C; Pass HI
    Curr Opin Pulm Med; 2008 Jul; 14(4):303-9. PubMed ID: 18520263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma.
    Friedberg JS
    Semin Thorac Cardiovasc Surg; 2009; 21(2):177-87. PubMed ID: 19822291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermic chemoperfusion for the treatment of malignant pleural mesothelioma.
    Mujoomdar AA; Sugarbaker DJ
    Semin Thorac Cardiovasc Surg; 2008; 20(4):298-304. PubMed ID: 19251168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodality management of malignant pleural mesothelioma: introduction.
    Sugarbaker DJ
    Semin Thorac Cardiovasc Surg; 2009; 21(2):95-6. PubMed ID: 19822279
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pleural mesothelioma: impact of the staging for the therapeutic strategy].
    Greillier L; Scherpereel A; Astoul P;
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S146-56. PubMed ID: 18235408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.